Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET-PF) Short-term Investments (2016 - 2025)

Metlife has reported Short-term Investments over the past 17 years, most recently at $3.6 billion for Q4 2025.

  • Quarterly results put Short-term Investments at $3.6 billion for Q4 2025, down 30.16% from a year ago — trailing twelve months through Dec 2025 was $3.6 billion (down 30.16% YoY), and the annual figure for FY2025 was $3.6 billion, down 30.16%.
  • Short-term Investments for Q4 2025 was $3.6 billion at Metlife, down from $6.0 billion in the prior quarter.
  • Over the last five years, Short-term Investments for MET-PF hit a ceiling of $12.2 billion in Q2 2021 and a floor of $3.0 billion in Q2 2022.
  • Median Short-term Investments over the past 5 years was $5.2 billion (2022), compared with a mean of $5.5 billion.
  • Biggest five-year swings in Short-term Investments: soared 127.82% in 2021 and later crashed 75.01% in 2022.
  • Metlife's Short-term Investments stood at $7.2 billion in 2021, then crashed by 31.23% to $4.9 billion in 2022, then rose by 22.49% to $6.0 billion in 2023, then dropped by 14.71% to $5.2 billion in 2024, then tumbled by 30.16% to $3.6 billion in 2025.
  • The last three reported values for Short-term Investments were $3.6 billion (Q4 2025), $6.0 billion (Q3 2025), and $5.3 billion (Q2 2025) per Business Quant data.